Valuation: Brooks Laboratories Limited

Market Cap 1.76B 18.52M 16.62M 15.35M 13.92M 26.01M 26.33M 184M 73.08M 922M 69.52M 68.03M 2.92B P/E 2025
-28.6x
P/E 2026 4.45x
Enterprise Value 1.78B 18.71M 16.8M 15.51M 14.06M 26.29M 26.61M 186M 73.85M 932M 70.25M 68.75M 2.95B EV / Sales 2025
3.93x
EV / Sales 2026 1.3x
Free-Float
45.16%
Yield 2025 *
-
Yield 2026 -
09-16 Brooks Laboratories Limited Announces Resignation of Krutika Rane as Company Secretary and Compliance Officer (Key Managerial Personnel), Effective October 9, 2026 CI
08-13 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-17 Brooks Laboratories Limited Announces Appointment of Rajesh Mahajan to President Trading and Senior Management Personnel, Effective July 17, 2026 CI
06-19 Steriscience Specialties Private Limited agreed to acquire an additional 16.33% stake in Brooks Steriscience Limited from Brooks Laboratories Limited for INR 1.1 billion. CI
05-29 Brooks Laboratories appoints Prashant Rathi as CEO RE
05-29 Brooks Laboratories names Prashant Rathi as CEO RE
05-29 Brooks Laboratories Limited Announces Appointment of Prashant Rathi as Chief Executive Officer, Effective June 1, 2026 CI
05-29 Brooks Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-07 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
16/10/25 Brooks Laboratories Limited Announces That Mr. Rajesh Mahajan Resigned as President - Procurement, with Effect from 16 October 2025 CI
13/08/25 Brooks Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
29/05/25 Brooks Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2025 CI
13/02/25 Brooks Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
1 day+0.30%
1 week-1.45%
Current month+7.35%
1 month+5.92%
3 months-4.54%
6 months-3.04%
Current year-25.26%
1 week 55.5
Extreme 55.5
64.29
1 month 52.97
Extreme 52.97
75.6
Current year 36.3
Extreme 36.3
82.44
1 year 36.3
Extreme 36.3
116
3 years 36.3
Extreme 36.3
198.86
5 years 36.3
Extreme 36.3
198.86
10 years 13.85
Extreme 13.85
198.86
Manager TitleAgeSince
Chief Executive Officer 58 23/01/2002
Chief Executive Officer - 01/06/2026
President 58 23/08/2023
Director TitleAgeSince
Director/Board Member 62 10/09/2010
Director/Board Member 61 13/09/2011
Director/Board Member 53 23/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%-1.45%-43.90%-43.97% 18.52M
+0.22%-0.14%+55.12%+128.82% 1,143B
+0.91%+3.61%+41.21%+84.57% 647B
-0.12%-0.93%+25.59%+106.14% 506B
-1.23%+0.59%+51.01%+63.41% 384B
+0.86%-4.37%+61.16%+37.93% 350B
-0.25%+1.37%+30.09%+51.98% 293B
-0.75%+0.95%+2.64%+24.62% 265B
+0.75%+2.05%+53.85%+71.25% 242B
+0.25%+1.64%+32.05%+107.62% 197B
Average -0.39%-0.06%+30.88%+63.24% 402.76B
Weighted average by Cap. -0.63%+0.71%+42.83%+87.78%

Financials

2025 2026
Net sales 826M 8.69M 7.8M 7.2M 6.53M 12.21M 12.36M 86.36M 34.3M 433M 32.63M 31.93M 1.37B 857M 9.03M 8.1M 7.48M 6.78M 12.68M 12.83M 89.68M 35.62M 449M 33.88M 33.16M 1.43B
Net income -99.67M -1.05M -942K -870K -789K -1.47M -1.49M -10.43M -4.14M -52.24M -3.94M -3.85M -166M 246M 2.59M 2.32M 2.14M 1.94M 3.64M 3.68M 25.71M 10.21M 129M 9.72M 9.51M 409M
Net Debt 75.39M 794K 712K 658K 596K 1.11M 1.13M 7.89M 3.13M 39.52M 2.98M 2.92M 125M 18.44M 194K 174K 161K 146K 273K 276K 1.93M 766K 9.66M 729K 713K 30.65M
Projected Income Statement - Annual - Brooks Laboratories Limited
Logo Brooks Laboratories Limited
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company. The Company specializes in supplying pharmaceutical products to government bodies, healthcare institutions, and large organizations. It operates through two segments, which include manufacturing and trading. The manufacturing segment comprises its own manufacturing operations and loan-licensing business relating to pharmaceutical products, ingredients, and intermediaries. The trading segment comprises principal-to-principal trading activities in pharmaceutical products, ingredients, and intermediaries. Its General Products offerings include Liquid Injection (Ampoules), Liquid Injection (Vials), Dry Powder Injections (Vials), Lyophilised Injections, Eye/Ear Drops, and Nasal Drops. The Company's Critical Care Division (CCD), operates through a robust distribution network, delivering injectables to hospitals and healthcare institutions across India.
Employees
347
Date Price Change Volume
28/10/26 ₹59.90 +0.30% 23,697
27/10/26 ₹59.72 +3.21% 24,757
26/10/26 ₹57.86 0.00% 53,859
23/10/26 ₹57.86 -5.29% 99,200
22/10/26 ₹61.09 +0.51% 54,438
  1. Stock Market
  2. Stocks
  3. BROOKS Stock